Lenalidomide, Adriamycin, and Dexamethasone (RAD) in Patients With Relapsed and Refractory Multiple Myeloma: A Report From the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
Blood - United States
doi 10.1182/blood-2008-10-184135
Full Text
Open PDFAbstract
Available in full text
Date
April 30, 2009
Authors
Publisher
American Society of Hematology